share_log

6-K: Novo Nordisk A/S Purchases B Shares Worth Dkk 5,428 Million from Novo Holdings A/S Under the 2024 Share Repurchase Programme

6-K: Novo Nordisk A/S Purchases B Shares Worth Dkk 5,428 Million from Novo Holdings A/S Under the 2024 Share Repurchase Programme

诺和诺德| 6-K:根据2024年股票回购计划,诺和诺德从Novo Holdings A/S购买价值54.28亿丹麦克朗的B股
美股SEC公告 ·  05/06 17:15
Moomoo AI 已提取核心信息
On May 6, 2024, Novo Nordisk A/S, a leading global healthcare company, announced the purchase of 6,311,250 B shares from Novo Holdings A/S, valued at DKK 5.43 billion. This transaction is a part of Novo Nordisk's 2024 share repurchase program, which is set to reach up to DKK 20 billion over a 12-month period starting February 6, 2024. The shares were bought at a price of DKK 860.02 each, based on the volume weighted average market price from May 2 to May 6, 2024. Prior to this transaction, Novo Holdings A/S held 28.3% of Novo Nordisk's share capital and 77.4% of the votes. Post-transaction, their stake slightly decreased to 28.2% of the capital and 77.3% of the votes. The share repurchase aligns with Novo Holdings A/S's intention to...Show More
On May 6, 2024, Novo Nordisk A/S, a leading global healthcare company, announced the purchase of 6,311,250 B shares from Novo Holdings A/S, valued at DKK 5.43 billion. This transaction is a part of Novo Nordisk's 2024 share repurchase program, which is set to reach up to DKK 20 billion over a 12-month period starting February 6, 2024. The shares were bought at a price of DKK 860.02 each, based on the volume weighted average market price from May 2 to May 6, 2024. Prior to this transaction, Novo Holdings A/S held 28.3% of Novo Nordisk's share capital and 77.4% of the votes. Post-transaction, their stake slightly decreased to 28.2% of the capital and 77.3% of the votes. The share repurchase aligns with Novo Holdings A/S's intention to maintain its ownership at approximately 28% of Novo Nordisk's share capital, as announced on January 31, 2024. Additionally, incentive programs at Novo Nordisk resulted in a net transfer of 93,461 B shares between May 2 and May 6, 2024. Following these transactions, Novo Nordisk holds 10,163,508 B shares as treasury shares, representing 0.2% of the share capital. The total number of A and B shares in the company, including treasury shares, is 4,465,000,000.
2024年5月6日,全球领先的医疗保健公司诺和诺德A/S宣布从Novo Holdings A/S购买6,311,2500亿股股票,价值54.3亿丹麦克朗。该交易是诺和诺德2024年股票回购计划的一部分,该计划将在2024年2月6日开始的12个月内达到高达200亿丹麦克朗。根据2024年5月2日至5月6日的成交量加权平均市场价格,这些股票以每股860.02丹麦克朗的价格收购。在本次交易之前,Novo Holdings A/S持有诺和诺德28.3%的股本和77.4%的选票。交易后,他们的股份略有下降至资本的28.2%和选票的77.3%。股票回购符合诺和控股公司于2024年1月31日宣布的将其所有权...展开全部
2024年5月6日,全球领先的医疗保健公司诺和诺德A/S宣布从Novo Holdings A/S购买6,311,2500亿股股票,价值54.3亿丹麦克朗。该交易是诺和诺德2024年股票回购计划的一部分,该计划将在2024年2月6日开始的12个月内达到高达200亿丹麦克朗。根据2024年5月2日至5月6日的成交量加权平均市场价格,这些股票以每股860.02丹麦克朗的价格收购。在本次交易之前,Novo Holdings A/S持有诺和诺德28.3%的股本和77.4%的选票。交易后,他们的股份略有下降至资本的28.2%和选票的77.3%。股票回购符合诺和控股公司于2024年1月31日宣布的将其所有权维持在诺和诺德股本约28%的意图。此外,诺和诺德的激励计划导致2024年5月2日至5月6日期间净转让了93,461亿股股票。在这些交易之后,诺和诺德持有10,163,508亿股股票作为库存股,占股本的0.2%。该公司的A股和B股总数,包括库存股,为44.65亿股。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息